Sana Biotechnology, Inc.

NASDAQ:SANA

1.7 (USD) • At close December 26, 2024
Bedrijfsnaam Sana Biotechnology, Inc.
Symbool SANA
Munteenheid USD
Prijs 1.7
Beurswaarde 379,557,300
Dividendpercentage 0%
52-weken bereik 1.55 - 12
Industrie Biotechnology
Sector Healthcare
CEO Dr. Steven D. Harr M.D.
Website https://www.sana.com

An error occurred while fetching data.

Over Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295

Vergelijkbare Aandelen

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

42.03 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

6 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

12.925 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

16.81 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

2.915 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

7.87 USD

National Research Corporation logo

National Research Corporation

NRC

17.94 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

8.98 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

0.579 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)